Shanghai Tongji Hospital, Tongji University School of Medicine
78
12
13
19
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 78 trials
100.0%
+13.4% vs industry average
9%
7 trials in Phase 3/4
0%
0 of 19 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (78)
Tobramycin Nebulization to Prevent Multidrug-Resistant Ventilator-Associated Pneumonia
Role: collaborator
Transcranial Electrical Stimulation for Comorbid Depression and Chronic Pain
Role: collaborator
Orelabrutinib Combined With Teniposide, Rituximab and Methotrexate for Newly Diagnosed PCNSL
Role: collaborator
Safety and Efficacy of Renal Denervation for Untreated Grade I Hypertension: a Pilot Study
Role: collaborator
Study on the Impact of Decolonization Treatment of Pneumocystis Jirovecii on the Frequency of Acute Exacerbation in COPD
Role: collaborator
A Multicenter Clinical Study of Romiplostim N01 in the Treatment of Sepsis-related Thrombocytopenia
Role: collaborator
Evaluating the Diagnostic Performance and Impact on Clinical Outcomes of the NuRapid-CRISPR Pathogen Profile Assay in ICU Patients With Sepsis
Role: collaborator
A Study of REGEND003 on Patients With Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD)
Role: collaborator
A Real-World Study Evaluating the Efficacy and Safety of Adebrelimab in Patients With Advanced SCLC
Role: collaborator
TH-CAR-027 for Grade 4 Gliomas
Role: lead
The National Registry Study For the Real-world Patients With Parkinsonian Disorders in China
Role: collaborator
Multi-omics Characterization and Model Construction of Colchicine Anti-inflammatory Therapy Efficacy in ACS Patients
Role: lead
A Clinical Study Exploring Universal CAR-T Cell in Patients With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
Role: lead
Efficacy and Safety Evaluation of U01(ssCART-19) in B-Cell Lymphoma
Role: lead
A Study Evaluating Safety and Efficacy of C-CAR039 Treatment in NHL Subjects
Role: lead
An Exploratory Clinical Study of the Efficiency and Safety of TH027 in the Treatment of Relapsed/Refractory Solid Tumors
Role: lead
An Exploratory Clinical Study Evaluating the Safety and Efficacy of Intravenous Anti-CD20/CD30-CAR-T Cell Infusion in Relapsed/Refractory Lymphoma Patients.
Role: lead
Gastroesophageal Reflux Disease Diagnostic Trial
Role: collaborator
Effects of Post-Operative Sedation for Endovascular Thrombectomy
Role: collaborator
A Study of C-CAR066 in Subjects With r/r B Cell Lymphoma Who Received CD19 CAR-T Therapy
Role: lead